Drug Profile
Monoclonal antibody UN3
Alternative Names: UN3Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 14 Jul 1998 Profile reviewed
- 14 Jul 1998 No-Development-Reported for Cancer in Italy (Unknown route)
- 23 Mar 1995 Preclinical development for Cancer in Italy (Unknown route)